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Many “complex” human diseases, which involve multiple genetic and environmental determinants, have increased
in incidence during the past 2 decades. During the same time period, considerable effort and expense have been
expended in whole-genome screens aimed at detection of genetic loci contributing to the susceptibility to complex
human diseases. However, the success of positional cloning attempts based on whole-genome screens has been
limited, and many of the fundamental questions relating to the genetic epidemiology of complex human disease
remain unanswered. Both to review the success of the positional cloning paradigm as applied to complex human
disease and to investigate the characteristics of the whole-genome scans undertaken to date, we created a database
of 101 studies of complex human disease, which were found by a systematic Medline search (current as of December
2000). We compared these studies, concerning 31 different human complex diseases, with regard to design, methods,
and results. The “significance” categorizations proposed by Lander and Kruglyak were used as criteria for the
“success” of a study. Most (66.3% [ ]) of the studies did not show “significant” linkage when the criterianp 67
of Lander and Kruglyak (1995) were used, and the results of studies of the same disease were often inconsistent.
Our analyses suggest that no single study design consistently produces more-significant results. Multivariate analysis
suggests that the only factors independently associated with increased study success are (a) an increase in the number
of individuals studied and (b) study of a sample drawn from only one ethnic group. Positional cloning based on
whole-genome screens in complex human disease has proved more difficult than originally had been envisioned;
detection of linkage and positional cloning of specific disease-susceptibility loci remains elusive.
Introduction
Complex human diseases involve multiple, interacting ge-
netic and environmental determinants (Weeks and La-
throp 1995). Many such diseases have increased in inci-
dence during the past 2 decades in the developed nations
and are of major clinical and economic significance. Dur-
ing the same period, the genetic etiology ofmany complex
human diseases has been increasingly emphasized as a
means of better understanding their pathogenesis, with
the ultimate goal of improving preventive strategies, di-
agnostic tools, and therapies (Risch 2000). During the
past decade, considerable effort and expense have been
expended in whole-genome screens aimed at detection of
genetic loci contributing to the susceptibility to complex
human diseases.
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Positional cloning begins with the identification of a
chromosomal region that is transmitted within families,
along with the disease phenotype of interest (genetic
linkage). Positional cloning has been extremely useful
in the identification of genes responsible for diseases
with simple Mendelian inheritance, such as cystic fi-
brosis (Zielenski and Tsui 1995). The ultimate goal of
positional cloning is to identify sequence variants within
the coding or controlling regions of a gene associated
with the phenotype of interest. However, the success of
such positional cloning attempts has been limited, and
most of the fundamental questions relating to the ge-
netic epidemiology of complex human disease remain
unanswered. In contrast to what has been found for
monogenic traits, the results have often been disap-
pointing or even inconsistent (Rao 2001; Terwilliger
and Goring 2000). The large amount of linkage data
generated from whole-genome screens is difficult to syn-
thesize and interpret.
Both to review the success of the positional cloning
paradigm as applied to complex human disease and to
investigate the characteristics of the whole-genome
scans undertaken to date, we created a database of 101
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Table 1
Lander and Kruglyak (1995) Significance Criteria for Mapping of
Loci Underlying Complex Traits in Sibs and Half-Sibs
Category
Range of
Approximate
P Values
Range of
Approximate
LOD Scores
No linkage 1.00–.0008 0–2.1
Suggestive linkage .0007–.00003 2.2–3.5
Significant linkage .00002–.0000004 3.6–5.3
Highly significant linkage .0000003 5.4
Confirmed linkage Significant linkage in an initial study,
confirmed in an independent sample
whole-genome scans of complex human disease, which
were found by a systematic Medline search. All studies
considered complex diseases in humans, described a
complete whole-genome scan (often excluding X and Y
chromosomes) and were published in peer-reviewed sci-
entific journals. This database, current as of December
2000, includes the majority of genome scans undertaken
in humans to date. We compared these studies, con-
cerning 31 different human complex diseases, with re-
gard to design, methods, and relative “success.”
Given the large number of whole-genome scans per-
formed to date—and the concomitant enormous ex-
penditure of research resources—a systematic review of
the success and characteristics of such studies seems
timely. We hypothesized that such a review might assist
researchers to find the appropriate design for their fu-
ture research work and might also facilitate the evalu-
ation of publications in this field. The principal aims of
this study were to review the success of whole-genome
scanning as a strategy for gene discovery in complex
human disease and to compare and analyze methodical
differences related to success in gene localization.
Material and Methods
Database
A database was created containing the following in-
formation: publication details (author, title, source, year
of study, and main trait); phenotypic traits investigated;
study design (environmental factors, number of associ-
ated traits, sibling recurrence risk ratio [lS], prevalence,
ascertainment background, phenotyping procedure, and
family structure); details of study population (ethnic
background and use of inbred/outbred populations);
sample-size details (number of probands, individuals,
families, and sib pairs); genotyping methods (type of
markers, number of markers, mean polymorphism in-
formation content, mean heterozygosity, mean spacing
of markers, and missing values); statistical methods; and
results obtained (number of positive markers concerning
the individual threshold, with localization and marker
term; maximum LOD score or Z score, and minimum
P value). When a “second-stage” (e.g., an additional
sample of families or additional markers) was reported
within the same publication, the database was supple-
mented with the relevant additional information.
The following initial keywordswere used for the search:
“genome-wide scan,” “genome-wide screen,” and “ge-
nome-wide search.” This entailed the reading and dis-
carding of several thousand titles and several hundreds of
abstracts of studies of monogenic diseases or animalmod-
els. The search was expanded by use of other terms found
to be commonly used in published whole-genome scans
(e.g., “susceptibility loci,” “genomic scan,” and “genome
screen”). The database was checked by examination of
both the discussion section and the reference list of the
publications found in our initial search, allowing the com-
pleteness of our database of genome scans in each specific
field to be validated. The database was current through
the end of December 2000.
Analysis
To investigate study properties that might have been
important in determining the relative success or lack of
success of the whole-genome scans investigated, it was
first necessary to generate some approximate measure
of success. The principal outcome variable generated for
each study was an ordinal measure of linkage success.
For every study, the most significant P value for linkage
was categorized and coded for analysis, by use of the
criteria of Lander and Kruglyak (1995): 0p no linkage;
1 p suggestive linkage; 2 p significant linkage; 3 p
highly significant linkage; and 4 p confirmed linkage
(table 1). This measure of “study success” (hereafter re-
ferred to as “L-K category”) was then used as an ordinal
outcome in bivariate and multivariate analyses to de-
termine the best predictors of success among the vari-
ables available for each published study.
Sample-size parameters, the number of markers geno-
typed, the average heterozygozity of genotyped markers,
the prevalence, and the lS for every disease were ana-
lyzed as continuous variables. L-K category and all other
variables were analyzed as categorical.
Bivariate analysis used x2 tests or Fisher’s exact tests
(Mehta 1994), for contingency tables or analysis of var-
iance, to compare L-K categories to study parameters of
interest. Generalized linear models (logistic regression)
(Armitage and Berry 1994) were used to model the ef-
fects of multiple covariates on L-K category.
Both forward and backward stepwise modeling pro-
cedures were used to select a useful subset of independent
predictors of study success. Checks of goodness of fit
(McCullagh and Nelder 1989) included an investigation
of the need for interaction or polynomial terms, analyses
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of residuals, and examination of the effect of observa-
tions with high regression leverage.
SAS version 8 (SAS Institute) was used to construct
the initial database. Both SAS version 8 and Splus ver-
sion 2000 (Mathsoft) were used to manage and analyze
data. Statistical significance was defined at the standard
5% level.
Results
1. Descriptive Statistics
Diseases and phenotypes studied.—The 101 studies in
our database were performed during 1993–2000, for 31
different complex human diseases (table 2). The most fre-
quently studied diseases were schizophrenia ( ),np 10
type 2 diabetes ( ), asthma ( ), bipolar affectivenp 8 np 7
disorder ( ), Crohn disease and inflammatory bowelnp 7
disease ( ), psoriasis ( ), obesity ( ), pros-np 7 np 6 np 5
tate cancer ( ), and type 1 diabetes ( ). Onlynp 5 np 5
four groups of authors published the results of more than
one whole-genome scan (Coon et al. 1993, 1994; Ginns
et al. 1996, 1998; Ober et al. 1998, 1999, 2000; Lee et
al. 2000a, 2000b). The lS and disease prevalence in an
appropriate reference population were generally not
stated in the articles reporting the whole-genome scans
but, for most complex diseases, were available from sec-
ondary literature. The lS values for the 31 diseases studied
were 1.3–75, with two peaks at ∼3–4 and ∼10–15. The
prevalence of the conditions studied in the general pop-
ulation also showed great variation, with a range of
0.04%–40% and a mean of ∼4%.
Most studies used disease affection status, coded as a
binary (i.e., yes or no) response, as the primary outcome
(74% [ ]). Twelve percent ( ) of studiesnp 75 np 12
used a disease-associated “intermediate” quantitative
trait as the primary outcome, and 14% ( ) of stud-np 14
ies used both disease affection status and one or more
disease-associated quantitative traits in their linkage
analysis.
Study design.—Fifty percent of all studies used an af-
fected-sib-pair design, and 14% used other pairs of af-
fected relatives. Nonaffected relatives (e.g., parents of
affected siblings and healthy siblings) were often geno-
typed also, to increase the information available for cal-
culation of identity-by-descent allele sharing at each
marker. In 36% of the studies, extended pedigrees were
ascertained.
Families were sampled mainly from outbred (i.e., non-
isolated), admixed populations (81% [ ]). The re-np 81
maining studies sampled genetically isolated, inbred
populations (19% [ ])—for example, an isolatednp 19
Finnish subpopulation (Hovatta et al. 1999), U.S. Hut-
terites (Ober et al. 1998, 1999, 2000), and Old Order
Amish (Ginns et al. 1996, 1998)—an approach that as-
sumes reduced heterogeneity both in genetic background
and in environmental and lifestyle factors. A study pop-
ulation sampled from a single ethnic group was inves-
tigated in the majority (64%) of studies; the remaining
studies (36%) sampled from two or more ethnic
groups—for example, individuals of European descent,
African American, and Hispanic (The Collaborative
Study on the Genetics of Asthma 1997).
Sample size.—The study size varied greatly between
studies, the range being 20–1,783 individuals comprised
by 1–580 families or pedigrees. The varying sample sizes
reflected the different ascertainment approaches and study
designs and were strongly related to the availability of
affected probands in the sampling frames used. Therewas
no significant difference in the mean number of individ-
uals studied, in terms of either year of study or disease
studied.
Genotyping methods.—The genotyping methods were
the most consistent aspect of the 101 whole-genome
screens investigated. All of the whole-genome scans were
based on the use of polymorphic microsatellite-marker
sets (Reed et al. 1994). There were only a limited number
of microsatellite marker sets (e.g., CHLC Weber, Ge´ne´-
thon, ResearchGenetics, andMarshfield) available during
the time frame of these studies; markers from these sets
were often combined with each other and sometimeswere
supplemented with specific polymorphic markers or sin-
gle-nucleotide polymorphisms (SNPs) in putative candi-
date chromosomal regions. The mean heterozygosity was
specified in only 46 studies, and the range was .60–.82.
The average spacing between any two microsatellite
markers in the whole-genome scans was 4.6–20 cM; the
majority of the studies had an average marker spacing of
∼11 cM.
Replication of results for specific diseases.—Some dis-
eases were the subject of multiple studies. When these
studies and their attained significance levels were com-
pared, it became obvious that it generally is difficult to
identify complex human diseases to replicate linkages
within them; for example, the number of studies showing
no linkage/suggestive linkage/significant linkage/highly
significant linkage/confirmed linkage breakdown was 1/
5/10/0 for asthma, 3/3/1/0/0 for bipolar affective dis-
order, 2/2/0/1/1 for psoriasis, 4/4/2/0/0 for schizophre-
nia, 0/2/1/1/1 for type 1 diabetes, and 0/2/6/0/0 for type
2 diabetes.
Table 3 compares the results of the seven studies of
asthma and the eight studies of type 2 diabetes. High-
lighting the difficulty of replication in linkage studies of
complex human diseases, these studies of asthma and
type 2 diabetes reported evidence of linkage on most of
the autosomes, and the majority of the reported positive
linkages did not overlap (table 3).
Distribution of all “positive” markers.—An average of
4.5 positive loci showing some evidence of linkage, which
Table 2
Characteristics of Whole-Genome Scans for Complex Human Disease ( )np 101
Main Trait (Primary Outcome) Reference(s)
No. of
Studies lS
Alcohol dependence (alcoholism and smoking) Long et al. (1998); Reich et al. (1998) 2 4
Atopy Ober et al. (1999) 1 1.3
Alzheimer Pericak-Vance et al. (1997); Kehoe et al. (1999) 2
Ankylosing spondylitis Brown et al. (1998) 1 46
Asthma (asthma and atopy) Daniels et al. (1996), The Collaborative Study on the Genetics of Asthma (1997), Ober et al. (1998, Wjst et
al. (1999), Dizier et al. (2000), 2000), Yokouchi et al. (2000)
7 3
Atopic dermatitis Lee et al. (2000b) 1
Autism International Molecular Genetic Study of Autism Consortium (1998), Philippe et al. (1999) 2 75
Bipolar affective disorder Coon et al. (1993), Ginns et al. (1996), McInnes et al. (1996), Adams et al. (1998), Detera-Wadleigh et al.
(1999), Morissette et al. (1999), Friddle et al. (2000)
7 15
Blood pressure (hypertension) Krushkal et al. (1999), Xu et al. (1999), Rice et al. (2000), Sharma et al. (2000) 4 4
Bone-mineral density (osteoporosis) Devoto et al. (1998), Niu et al. (1999) 2
Cholesterol concentration (familial combined
hyperlipidemia)
Aouizerat et al. (1999), Pajukanta et al. (1999), Rainwater et al. (1999) 3 20
Crohn disease (inflammatory bowel disease) Hugot et al. (1996), Satsangi et al. (1996), Cho et al. (1998), Hampe et al. (1999), Ma et al. (1999), Duerr
et al. (2000), Rioux et al. (2000)
7 35/25
Diabetes:
Type 1 Davies (1994), Field et al. (1994), Hashimoto et al. (1994), Luo et al. (1995), Mein et al. (1998) 5 15
Type 2 (BMI/age at onset/plasma glucose concentration/
prediabetic phenotype)
Hanis et al. (1996), Mahtani et al. (1996), Stern et al. (1996), Hanson et al. (1998),
Pratley (1998), Duggirala et al. (1999), Elbein et al. (1999), Hegele et al. (1999), Ehm et al. (2000), Wa-
tanabe et al. (2000)
10 4
IgE level, total serum Xu et al. (2000) 1
Interphalangeal-joint osteoarthritis Leppavuori et al. (1999) 1
Lupus erythematosus Gaffney et al. (1998), Moser et al. (1998), Shai et al. (1999) 3 15
Mental-health wellness Ginns et al. (1998) 1
Multiple sclerosis Ebers et al. (1996), Haines et al. (1996), Sawcer et al. (1996), Kuokkanen et al. (1997) 4 30
Obesity, energy metabolism, leptin variation Comuzzie et al. (1997), Hager et al. (1998), Norman et al. (1998), Lee et al. (1999), Ohman et al. (2000) 5 4
Open-angle glaucoma Wiggs et al. (2000) 1 8
Osteoarthritis Chapman et al. (1999) 1 23
Panic disorder Knowles et al. (1998) 1 8
Pre-eclampsia (eclampsia) Harrison et al. (1997), Arngrimsson et al. (1999) 2
Prostate cancer (aggressive prostate cancer) Smith et al. (1996), Berthon et al. (1998), Gibbs et al. (1999), Suarez et al. (2000), Witte et al. (2000) 5 3
Psoriasis Tomfohrde et al. (1994), Matthews et al. (1996), Nair et al. (1997), Trembath et al. (1997), Samuelsson et
al. (1999), Lee et al. (2000a)
6 7
Raynaud phenomenon Susol et al. (2000) 1
Rheumatoid arthritis Cornelis et al. (1998), Shiozawa et al. (1998) 2 5/8
Schizophrenia Coon et al. (1994), Moises et al. (1995), Blouin et al. (1998), Faraone et al. (1998), Kaufmann et al. (1998),
Levinson et al. (1998), Shaw et al. (1998), Hovatta et al. (1999), Williams et al. (1999), Ekelund et al.
(2000)
10 10
Testicular tumor Leahy et al. (1995), Rapley et al. (2000) 2 9
Tuberculosis Bellamy (2000) 1
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Figure 1 Regression analysis of expected and observed hits on
chromosomes 1–22 and X. An average of 4.5 “positive” loci showing
some evidence of linkage, chosen by different individual thresholds,
were reported in every study. The observed hit ratio (%: hits on every
chromosome/all 453 hits) is plotted against the expected hit ratio (%:
genes on every chromosome/all 37,701 genes of the genome, when
chromosome sizes and gene content are rated as suggested by Venter
et al. [2001]).
Table 3
Comparison of Loci Found in Studies of Asthma and Type 2 Diabetes
Disease and Reference Study Design
No. of
Individuals
Genotyped Significance Levela
Chromosome(s) for Which
Positive Findings Were Reported
Asthma:b
Daniels et al. (1996) Sib pair 364 Suggestive linkage 4, 6, 7, 11, 13, 16
The Collaborative Study on the
Genetics of Asthma (1997)
Sib pair 540 Suggestive linkage 2, 5, 6, 11–14, 17, 19, 21
Ober et al. (1998) Extended pedigree 361 Suggestive linkage 2, 3, 5, 9, 12, 13, 19, 21
Wjst et al. (1999) Sib pair 415 No linkage 2, 6, 9, 12
Dizier et al. (2000) Sib pair 211 Suggestive linkage 1, 11–13, 17, 19
Ober et al. (2000) Extended pedigree 693 Suggestive linkage 5, 8, 14, 16, 19
Yokouchi et al. (2000) Sib pair 197 Significant linkage 4, 5, 13
Type 2 diabetes:c
Hanis et al. (1996) Sib pair 408 Significant linkage 2
Mahtani et al. (1996) Extended pedigree 217 Significant linkage 12
Hanson et al. (1998) Affected relatives 656 Suggestive linkage 11
Duggirala et al. (1999) Extended pedigree 440 Significant linkage 3, 4, 9, 10
Elbein et al. (1999) Extended pedigree 468 Significant linkage 1
Hegele et al. (1999) Sib pair 33 Significant linkage 3, 6, 8, 10, 16, 22
Ehm et al. (2000) Affected relatives 1,783 Significant linkage 3, 5, 10, 12, X
Ghosh et al. (2000) Sib pair 1,438d Suggestive linkage
a Defined on the basis of the criteria of Lander and Kruglyak (1995).
b There were 42 linkage hits on 17 different chromosomes—3 each on chromosomes 5, 12, and 19 and 5 on chromosome 13.
c There were 25 linkage hits on 15 different chromosomes—3 on chromosome 3 and 4 on chromosome 10.
d 719 sib pairs.
were chosen on the basis of different individual thresh-
olds, were reported in every study. These 453 “hits” were
not distributed equally among all 23 chromosomes.
We plotted the observed hit ratio (%: hits on every
chromosome/all 453 hits) against an expected hit ratio
(%: genes on every chromosome/all 37,701 genes of the
genome, when chromosome sizes and gene content are
rated as suggested by Venter et al. [2001]). The linear
regression suggested a close correlation between the ex-
pected hit ratio and the observed hit ratio (fig. 1). This
suggests that the null hypothesis of random linkages
across the genome cannot be rejected, since all the whole-
genome scans investigated usedmarkers (roughly) equally
distributed across the genome and a close association of
the positive linkages with theoretical gene-content could
be shown.
However, chromosomes 4, 6, and 16 showed an in-
creased observed hit ratio, relative to the expected hit
ratio. This may indicate the presence of one or more
pleiotropic loci encoding susceptibility for multiple dis-
eases and traits. Markers in or near the HLA locus on
chromosome 6p, for example, show some evidence of
linkage to type 1 diabetes (Davies et al. 1994; Field et
al. 1994; Hashimoto et al. 1994; Mein et al. 1998),
multiple sclerosis (Haines et al. 1996; Kuokkanen et al.
1997), rheumatoid arthritis (Cornelis et al. 1998), pso-
riasis (Nair et al. 1997; Trembath et al. 1997; Samuels-
son et al. 1999; Lee et al. 2000a), inflammatory bowel
(Hampe et al. 1999; Rioux et al. 2000), and asthma/
allergy (Daniels et al. 1996; The Collaborative Study on
the Genetics of Asthma 1997; Ober et al. 1999; Wjst et
al. 1999).
2. Analysis
Many different linkage-analysis techniques and models
(e.g., model-based and model-free methods, two-point
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Table 4
Relationship of Study Variables to Study Success
VARIABLE NO LINKAGE SUGGESTIVE LINKAGE SIGNIFICANT LINKAGE
HIGHLY
SIGNIFICANT LINKAGE
CONFIRMED
LINKAGE
Proportion (No.) of Studies Successfula
Ascertainment:
Affected sib pairs 21.6% (11) 45.1% (23) 23.5% (12) 7.8% (4) 2.0% (1)
Affected relative pairs 7.1% (1) 50.0% (7) 35.7% (5) .0% 7.1% (1)
Extended pedigrees 22.2% (8) 47.2% (17) 27.8% (10) 2.8% (1) .0%
Population:
Outbred, admixed 19.5% (16) 45.1% (37) 26.8% (22) 6.1% (5) 2.4% (2)
Inbred, isolated 21.0% (4) 52.6% (37) 26.3% (5) .0% .0%
Primary outcome investigated:
Qualitative 34.0% (18) 38.7% (29) 28.0% (21) 6.7% (5) 2.7% (2)
Quantitative 8.3% (1) 83.3% (10) 8.3% (1) .0% .0%
Qualitative and quantitative 7.1% (1) 57.1% (8) 35.7% (5) .0% .0%
No. of ethnic groups studied:
One 16.4% (10) 42.6% (26) 29.5% (18) 8.2% (5) 3.3% (2)
More than one 22.9% (8) 54.3% (19) 22.9% (8) .0% .0%
Mean (SE)
No. of families studied 75.8 (17.7) 92.4 (16.3) 97.9 (18.6) 112.8 (43.2) 68.5 (27.5)
No. of individuals studied 243.9 (38.5) 393.6 (49.2) 470.5 (69.4) 435.0 (189.0) 331.0 (69.0)
Disease prevalence (%) 4.0 (1.6) 5.2 (1.4) 3.4 (.8) 1.1 (.6) 1.1 (.8)
lS 15.1 (10.0) 12.3 (2.2) 12.1 (2.3) 20.2 (7.2) 11.0 (4.0)
a Success measures are L-K categories.
and multipoint linkage analysis, and variance-compo-
nents and regression-basedmethods) were usedwithin the
available software packages. LOD scores and Z scores
were transformed into asymptotic P values, if these were
not already listed.
When classification on the basis of L-K category was
used, 4% ( ) of the whole-genome scans showednp 4
highly significant linkage, 24% ( ) showed signif-np 23
icant linkage, 47% ( ) showed suggestive linkage,np 44
and the remaining 24% ( ) showed little (oftennp 23
referred to as “nominal” linkage). Forty-one studies re-
ported more than one “stage” in the same publication. A
“second stage” genome screen generally involved either
a second whole-genome scan, the typing of selectedmark-
ers on a second sample of families, in an attempt to rep-
licate the positive findings of the initial genome scan, or
the typing of a denser marker set (“flanking markers”) in
certain regions in the same sample of families. Approxi-
mately half of these second stages led to an improvement
in the statistical significance of individual linkages. The
reporting of these second-stage approaches in some of the
reviewed studies made it necessary to redefine study suc-
cess, beyond what each article simply reported for the
initial (first-stage) “genomewide-scan result.” This “over-
all study result” was used as the primary outcome in our
analyses and considers the lowest P value attained either
in one of the study stages or in the combined sample data.
When classification on the basis of L-K categorywas used,
2% ( ) of the studies showed confirmed linkage, 5%np 2
( ) showed highly significant linkage, 27% (np 5 np
) showed significant linkage, 46% ( ) showed27 np 47
suggestive linkage, and 20% ( ) showed no linkage.np 20
Bivariate analysis.—Bivariate analysis found no sig-
nificant association between study success, as defined by
L-K category, and the following study parameters (table
4): ascertainment (Fisher’s exact test; ); popu-Pp .21
lation studied—either inbred/outbred (Fisher’s exact
test; ) or one ethnic group/more than one ethnicPp .92
group (Fisher’s exact test; ); primary outcomePp .28
investigated (qualitative/quantitative/both) (Fisher’s ex-
act test; ); number of families studied (Pp .23 F p4,93
; ); number of individuals studied (0.22 Pp .92 F p4,94
; ; see fig. 2); disease prevalence (1.52 Pp .20 F p4,88
; ); and lS ( ; ; see fig.0.61 Pp .66 F p 0.48 Pp .754,78
3). However, the following variables showed some trend
toward an association with higher L-K category (table
4): study of only one ethnic group; number of individuals
studied (fig. 2); and study of an outbred population.
Multivariate analysis.—Ordinal logistic regression sug-
gested that both the number of individuals studied (odds
ratio p 1.004/subject, 95% confidence interval p
1.001–1.008; ) and the study of one ethnicPp .03
group (vs. multiple ethnic groups) (odds ratio p 2.44,
95% confidence interval p 1.08–5.54; ) werePp .03
associated with increased study success. These associa-
tions were independent of (1) the specific disease studied,
(2) the type of trait investigated as the primary outcome,
(3) the ascertainment method, (4) either lS or the pop-
ulation prevalence of the condition studied, or (5) sta-
tistical test used.
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Figure 2 Number of individuals, plotted against minimum at-
tained P value. The correlation of sample size and study “success” in
the genome scans reviewed is illustrated. The vertical lines correspond
to the significance thresholds suggested by Lander and Kruglyak
(1995), and the mean number of individuals studied in each category
is shown.
Figure 3 lS, Plotted against minimum attained P value. The
correlation of lS and study “success” in the genome scans reviewed
is illustrated. The vertical lines correspond to the significance thresh-
olds suggested by Lander and Kruglyak (1995), and the mean lS in
each category is shown.
Discussion
Our review was designed to compare 101 whole-genome
scans in 31 different diseases, in terms of design, meth-
ods, and success. Studies varied widely with regard to
study design and statistical analysis. Most studies did
not show significant linkage when the criteria of Lander
and Kruglyak (1995) were used. The findings in studies
of the same disease are often inconsistent; the number
of observations of highly significant and confirmed link-
ages is very small, and unequivocal statements are dif-
ficult to make.
Although this review has focused on one dimension
of the success of whole-genome scans, it is important
to remember that the underlying purpose of such studies
is to discover susceptibility loci for a complex dis-
ease—the real success of a whole-genome scan is un-
likely to be defined solely by the minimum attained P
value of the linkage analysis. Potential publication bias
was ignored in our review. There are a number of ge-
nome scans of complex human diseases, known to have
been undertaken by private industry, that have not been
published. The involvement of commercial enterprises
in gene-discovery attempts has put a premium on se-
crecy, and the results of these genome scans could not
be included in this review. There has been no systematic
assessment of publication bias in whole-genome screens,
and such an undertaking was beyond the scope of our
review. However, the lack of evidence of a correlation
between year of publication and study success suggests
that this was not an important bias in the sample of
whole-genome screens surveyed. A further potential bias
in our study relates to the way in which the Medline
search was undertaken. Validation of our database by
the discussions and reference lists in primary literature
discovered in an initial Medline search may have led to
the inclusion of a disproportionate number of the ge-
nome scans of the more frequently investigated diseases.
The use of Lander and Kruglyak’s (1995) proposed
categorizations as an approximate measure of study suc-
cess is somewhat arbitrary and could have biased our
study in unknown ways. In their article, Lander and
Kruglyak (1995) argue strongly for the value of such
categorizations, and their scheme has been adopted by
many researchers. However, to ensure that our cate-
gorization of success had not biased our study, we also
repeated our analyses, using, as a continuous outcome,
log10 (minimum P values) from each study. The results
were very similar to those reported when the L-K cat-
egories (data not shown) were used, suggesting that the
use of this categorization scheme did not result in any
significant bias.
Our analysis suggests that sample size is an important
determinant of study success. Possibly because the ex-
tended-pedigree approach has low numbers of families
and proportionally higher numbers of individuals, the
number of individuals studied proved to be the most
informative index of sample size. The most obvious dif-
ferences in study success that were due to sample size
were observed for the difference between no linkage and
any evidence of suggestive or better linkage (fig. 2); on
average, studies that, by Lander and Kruglyak (1995)
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criteria, showed suggestive linkage had twice the sample
size (number of individuals) of studies showing no ev-
idence of linkage.
The study of a sample selected from a single ethnic
group also appeared to be advantageous with regard to
L-K category attained. This may be due both to the in-
crease in heterogeneity in the study sample, occasioned
by introduction of samples from different ethnic groups,
and to the current general lack of appropriate statisti-
cal methodology to assess or adjust for the resulting in-
creased heterogeneity.
It has been proposed that, compared with outbred,
admixed populations, genetically isolated populations
may offer some advantages for the mapping of complex
genetic traits (de la Chapelle 1993; Jorde 1995). How-
ever, both in contrast to the theoretical advantages to the
use of inbred populations position and in accord with
some recent statistical concerns (Lonjou et al. 1999), the
empirical data show that studies using such populations
are, on average, no more successful than studies using
samples from general, outbred populations. This finding
may be the result of factors such as either the lack of
availability of an available inbred population for study
of a particular disease or, possibly, to disadvantages in-
herent in an extended-pedigree approach.
Rare diseases are generally more difficult to investigate
in a large study, since (a) study design is often limited by
the number of available samples and (b) collecting a large
number of families containing one or more affected in-
dividuals can be problematical. However, our review sug-
gests that there is no identifiable disadvantage associated
with the study of rarer complex diseases compared with
more-common diseases.
It has been generally accepted that quantitative “in-
termediate” phenotypes, when available, are likely to be
more objective and informative—and, hence, more sta-
tistically powerful—and hence preferable to dichotomous
disease affection outcomes (Amos and Laing 1993).
However, our analyses do not suggest that, as outcomes
for linkage analysis, quantitative traits have any impor-
tant advantages over qualitative traits. Given that many
different diseases were studied by many disparate meth-
ods, it is difficult to ascribe meaning to this finding. Pos-
sibly the intraindividual fluctuations over time, as well
as difficulties in consideration of covariate adjustment
for quantitative intermediate phenotypes may bias the
phenotypes, introducing noise into the linkage analysis.
lS is a variable that characterizes the familial aggre-
gation of a disease; the lS value can be used to estimate
the power that affected-sib-pair methods have to detect
linkage (Risch 1990). Whole-genome scans have suc-
ceeded in the analysis of monogenic traits, which tend
to have extremely high estimated lS values (Farrer and
Cupples 1998). The results of gene mapping in mono-
genic disease, together with theoretical studies of lS val-
ues (Risch 1990), suggest that genes for complex diseases
with a relatively high lS may be more easily localized.
However, our results are not consistent with this theo-
retical expectation (fig. 3). This finding calls into question
whether the lS measure has utility for linkage studies of
common, complex human diseases.
The comparison of variables related to study design
and power vis-a`-vis the best L-K category attained in
every study may only suggest some more-obvious trends
and does not prove that the observed differences are crit-
ical to success. Our results suggest that, beyond the al-
most tautological finding that larger samples and reduced
heterogeneity are better, there is no gold standard appli-
cable to complex human diseases. One recommendation
that we do feel confident to make is that, in publications
of whole-genome scans, more-careful attention should be
paid to the characterization of both the methods (par-
ticularly the ascertainment and the phenotyping proce-
dures) and the results. Undertaking our review was made
extremely difficult by the inconsistency of the studies re-
viewed, in terms of their reporting ofmethods and results;
a degree of subjective interpretation was often necessary
in order to identify all of the relevant parameters from
a study. Linkage results were sometimes presented pri-
marily as LOD-score or P-value diagrams (often small
and hard to read) for each chromosome. Very few studies
gave any information regarding marker informativity,
making it impossible to study this parameter. Detailed
descriptions of methodology (particularly for studies in-
volving multiple stages) and the reporting of maximum
LOD scores and/or minimum P values in tabular form
(in addition to or instead of graphic representations)
would much improve the situation. There is a lack of
generally accepted criteria for replication of linkage re-
sults; it remains unclear exactly what constitutes “rep-
lication” in a genome scan. For the purposes of our re-
view, we took reported replication at face value, even
though this may involve different criteria (e.g., within 10
cM vs. within 5 cM) in different studies. Finally, as
Lander and Kruglyak (1995) argue, ideally every indi-
vidual whole-genome screenwould report empirically de-
termined significance criteria for that study. These prob-
lems are as much the fault of journal editors as they are
of individual authors, and they need to be addressed by
comprehensive, uniform guidelines.
The whole-genome screens for complex human dis-
ease that have been reviewed here have a number of
important limitations. Sample sizes were generally mod-
est; the relatively small numbers studied would have (a)
tended to limit the power of these genome screens to
detect linkage and (b) increased the possibility of type
I experimental error (Terwilliger and Goring 2000). The
use of widely differing significance thresholds within
each sample make it difficult to compare them. In most
of the studies, no replication of putative novel linkages
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has yet been attempted in independent population sam-
ples of similar ethnicity. Furthermore, the (often tacit)
assumption that the susceptibility genes for quantitative
traits associated with disease affection will be equivalent
to the susceptibility genes for the disease in question
may not necessarily be valid. However, it is easy to be
critical in hindsight, and it is important to recognize
that these studies are embedded within a historical ma-
trix; the many difficulties inherent in positional cloning
have become apparent only through the experience
gained during the past decade.
What Studies That Showed Highly Significant or
Confirmed Linkage Have in Common
Five studies showed one or more highly significant link-
ages, and two showed confirmed linkage (Davies et al.
1994; Field et al. 1994; Tomfohrde et al. 1994; Satsan-
gi et al. 1996; Trembath et al. 1997; Brown et al. 1998;
Shiozawa et al. 1998). All seven of these studies used a
qualitative main trait (in two studies of type 1 diabetes,
one study of rheumatoid arthritis, one study of ankylosing
spondylitis, one study of inflammatory bowel disease, and
two studies of psoriasis) and sampled from outbred pop-
ulations, and five of them used a sib-pair approach. Were
these results obtained by chance (a “lucky” search for the
right trait in the right families), or do these studies have
something else in common? Although a significant rela-
tionship between sample size and attained significance
level could be demonstrated, the most-significant results
were not achieved by the largest studies in this group. No
clear strategy for success could be delineated by our re-
view, except perhaps a preference for autoimmune dis-
eases. The success of studies of such diseases may reflect
both an increased genetic component of variance and re-
duced locus heterogeneity, relative to the other diseases
investigated. Study design also may have played a role;
the selection of families was generally undertaken with
the aim of focusing either on a well-defined subtype of
the disease or on large pedigrees in which the disease
appeared to exhibit Mendelian inheritance (e.g., see Tom-
fohrde et al. 1994; Brown et al. 1998).
For type 1 diabetes, larger numbers of families were
collected (Davies et al. 1994; Field et al. 1994), and both
studies of this disease reported that their best linkage re-
sults were for markers in the HLA region on chromosome
6p21. This locus also was found in other studies of type
1 diabetes (Hashimoto et al. 1994; Mein et al. 1998).
These findings suggest that, at least in some diseases, the
positional-cloning paradigm holds true—that is, an im-
portant locus can be found and replicated.
Future Directions
Although, during the past decade, significant progress
has been made in defining the genetic basis of complex
human diseases, even relatively large studies are likely to
have had low power to map, by linkage, genes of modest
effect (Risch 2000; Terwilliger and Goring 2000). One
potential solution to this and other issues is to combine
data from multiple studies. Meta-analysis is an emerging
methodology in the linkage analysis of complex-disease
genetics (Morton 1995; Rice 1997; Gu et al. 1998; Xu
and Meyers 1998; Badner and Goldin 1999; Guerra et
al. 1999; Wise and Lewis 1999); the combination of ev-
idence from multiple studies may prove to be critical to
the successful localization of genes of modest effect in
common complex human diseases (Palmer et al. 2001a,
2001c; The Transatlantic Multiple Sclerosis Genetics Co-
operative 2001).
Our results suggest that some elements of study design
are likely to be important in the determination of the
relative success of a whole-genome scan. Every individual
study and disease is likely to require an optimized study
design that takes into account the unique characteristics
of both that sample and the phenotypes studied (Terwil-
liger and Goring 2000). Our review suggests that atten-
tion to maximization of sample homogeneity is likely to
be particularly important. Unfortunately, this cart is often
placed a long distance before the horse: linkage analysis
is very often attempted before appropriate descriptive
analyses—to allow informed study design and genetic
analysis in the sampling frame in question—are under-
taken to determine the interrelationships of the pheno-
types and covariates being studied; for example, although
asthma has been the subject of many genome scans (table
3), only recently have the interrelationships between the
underlying genetic determinants of intermediate pheno-
types begun to be investigated (Palmer et al. 2000, 2001b).
It is to be hoped that the recent advent of cheaper and
improved computing power, together with methodolog-
ical advances in complex modeling techniques (e.g., see
Zeger and Karim 1991), will lead to the continuing de-
velopment and application of new computing-intensive
statistical methodologies that are ideal for complex ge-
netic modeling. Finally, an understanding of the genetic
epidemiology ofmany diseases would be greatly enhanced
by population-based studies. Such studies, although ex-
pensive and difficult to undertake, are the foundation of
good genetic epidemiology and address many important
epidemiological issues, such as generalization (Hopper et
al. 1999).
Conclusions
Gene discovery in complex human disease has been com-
plicated by substantial etiological heterogeneity, the pos-
sibility of genes of small effect, and the concomitant re-
quirement for large samples. The mapping of human
susceptibility loci for such diseases may be made difficult
by any or all of the following: high population frequency,
incomplete penetrance, phenocopies, genetic heterogene-
ity, possible epistasis, and pleiotropy (Weeks and Lathrop
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1995); replication of any positive results may be difficult,
and often the significance of studies’ different findings is
controversial. As a consequence, the application of link-
age analysis to complex disorders without obvious Men-
delian inheritance has had limited success thus far.
Genetic approaches to complex diseases offer great po-
tential to improve our understanding of the pathophysiol-
ogy of these disorders, but they also offer significant chal-
lenges. Although the past decade made great progress in
defining the genetic basis of such diseases, accompanied
by rapid technical progress in genotyping technologies
and statistical methodology, further research is required,
especially in the area of study design. In particular, the
genetic localization of most susceptibility loci is still in-
sufficiently precise for the positional cloning of new
genes influencing disease. There have been linkages re-
ported on nearly every autosome, in multiple whole-
genome screens for the same disease, and the sheer num-
ber of “consensus regions” identified by such screens
highlights the difficulty of positional-cloning attempts
in common complex diseases such as asthma and dia-
betes (Lander and Schork 1994; Palmer and Cookson
2000). Whether positional cloning based on whole-ge-
nome screens ultimately delivers on its promises for
complex human diseases remains to be seen. It may be
that high-density SNP association analysis in combi-
nation with functional genomic data may prove to be
necessary to detect susceptibility loci (which may be of
small effect) for many complex human diseases (Risch
2000). In the meantime, like true love, true linkage re-
mains hard to find.
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